David F. Stroncek
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation 80
- Blood groups and transfusion 53
- Biochemistry top 0.2%
- Immunology top 0.5%
- Immunotherapy and Immune Responses 56
- Immune Cell Function and Interaction 55
- Oncology top 0.5%
- CAR-T cell therapy research 108
- Genetics top 0.5%
- Blood disorders and treatments 66
- Virus-based gene therapy research 42
- Mesenchymal stem cell research 40
- Co-authors
- Francesco M. MarincolaPing JinJiaqiang RenMarianna SabatinoPaolo RebullaEna WangSusan F. LeitmanMary Clay
- Cited by
- HematologyBiochemistryImmunology
- Partner nations
- United StatesGermanyItaly
In The Last Decade
David F. Stroncek
388 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Hematology 3.3k
- Biochemistry 1.4k
- Immunology 3.8k
- Oncology 4.4k
- Genetics 1.6k
Countries citing papers authored by David F. Stroncek
This map shows the geographic impact of David F. Stroncek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David F. Stroncek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David F. Stroncek more than expected).
Fields of papers citing papers by David F. Stroncek
This network shows the impact of papers produced by David F. Stroncek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David F. Stroncek. The network helps show where David F. Stroncek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David F. Stroncek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 31 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 13 | |
| 13 | 2021 | 4 | |
| 14 | Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLbreakdown → | 2021 | 200 |
| 15 | 2017 | 23 | |
| 16 | 2017 | 33 | |
| 17 | 2012 | 1 | |
| 18 | 2006 | 11 | |
| 19 | 2005 | 467 | |
| 20 | 1996 | 27 |
About David F. Stroncek
David F. Stroncek is a scholar working on Hematology, Immunology and Oncology, having authored 397 papers that have together received 12.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (108 papers), Hematopoietic Stem Cell Transplantation (80 papers), Blood disorders and treatments (66 papers), Immunotherapy and Immune Responses (56 papers), Immune Cell Function and Interaction (55 papers), Blood groups and transfusion (53 papers), Virus-based gene therapy research (42 papers) and Mesenchymal stem cell research (40 papers). The work is most often cited by research in Hematology (3.3k citations), Biochemistry (1.4k citations) and Immunology (3.8k citations). David F. Stroncek has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Francesco M. Marincola, Ping Jin, Jiaqiang Ren, Marianna Sabatino, Paolo Rebulla, Ena Wang, Susan F. Leitman, Mary Clay, Christopher C. Silliman and Mark A. Popovsky.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.